IRCCS Policlinico S. Donato

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

1 drugs in development

Phase 31

By Therapeutic Area

top 1

Cardiovascular

1100%

R&D Momentum

58/100

Pipeline Velocity

22/100

Trial Completion Rate

85/100

Pipeline Concentration

100/100

Pipeline Freshness

69/100

Activity

Recent Activity

Last 14 days

Nov 5, 2026

Recruiting

Study of the Transcriptomic Alterations in Heart Failure and Aortic Stenosis

Nov 5, 2026

Recruiting

Anomalous Aortic Origin of Coronary Artery: From Pathophysiology to Risk Stratification Through a Patient Specific Computational Simulation Model

Nov 4, 2026

Completed

THERAPEUTIC PHOTOGRAPHY AND EXPRESSIVE WRITING: AN EXPLORATORY SEQUENTIAL MIXED-METHODS FEASIBILITY STUDY OF PATIENTS WITH MARFAN SYNDROME

Earlier

Oct 17, 2026TrialPharmacological Optimization in Prevention in Heart Failure: A Sex-gap?

Oct 17, 2026TrialAnalysis of Muscle Morphological and Electromechanical Properties in Patients With MFS and EDS: a Low-risk Intervention Study

Oct 17, 2026TrialProtocollo Sulla Valutazione Del RischiO cardioVAscolare Nel Crohn e ColIte Ulcerosa (PROVACI). Estimation of Cardiovascular Risk in Crohn's Disease and Ulcerative Colitis

Oct 17, 2026TrialDissecting the Complexity of Inflammatory Bowel Disease (IBD) A Prospective Study With Focus on Cardiovascular Risk

Oct 14, 2026TrialSMART: Speed-up the Diagnosis and Evaluation of anoMalous Coronary ARTery From the Aorta.

4 more events

Aug 28, 2026TrialData-driven Clustering in Hemorrhoid Surgery: Retrospective Monocentric Study for the Identification of Clinical Phenotypes

Aug 28, 2026TrialScATtEred Rare Disease Biobanks: a Model of Sample/Data Collection With susTainablE and Shared Criteria SATELLITES

Jul 28, 2026TrialENDOSCOPIC CLASSIFICATION OF FUNDOPLICATION INTEGRITY PREDICTS PATHOLOGIC REFLUX: DEVELOPMENT AND PROSPECTIVE VALIDATION

Jul 25, 2026TrialInternational Multicenter Study of the Navitor/Navitor Vision Transcatheter Aortic Valve Platform (The Intensive Study)

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Pipeline

Drug Pipeline

Indication

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Cardiovascular

Heart Failure

Guideline-Directed Medical Therapy (GDMT)

Cardiovascular

Heart Failure

Guideline-Directed Medical Therapy (GDMT)Phase 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)